---
title: "NPPA caps trade margin on 137 non-scheduled anti-cancer medicines at 30% of MRP — DecisionGateway"
description: "India's NPPA capped trade margins on 137 non-scheduled anti-cancer medicines at 30% of MRP, which led companies to cut MRPs substantially and is expected to sav"
canonical_url: "https://dgw.tmarket.io/decisions/01a1df4d-5911-70a7-b913-9de5745d10de"
meta:
  "og:description": "India's NPPA capped trade margins on 137 non-scheduled anti-cancer medicines at 30% of MRP, which led companies to cut MRPs substantially and is expected to sav"
  "og:image": "https://dgw.tmarket.io/og.jpg"
  "og:image:alt": "White network of connected nodes crossed by a timeline on black"
  "og:image:height": "1024"
  "og:image:width": "1024"
  "og:title": "NPPA caps trade margin on 137 non-scheduled anti-cancer medicines at 30% of MRP — DecisionGateway"
  "twitter:image": "https://dgw.tmarket.io/og.jpg"
---

> Index of every page on this site: [llms.txt](https://dgw.tmarket.io/llms.txt)

**Decision**/Regulate/17 Oct 2026

**Adopted**

# **NPPA caps trade margin on 137 non-scheduled anti-cancer medicines at 30% of MRP**

India's NPPA capped trade margins on 137 non-scheduled anti-cancer medicines at 30% of MRP, which led companies to cut MRPs substantially and is expected to save patients and the system an estimated ₹3,541 crore.

## **Actors and targets**

Targets 137 non-scheduled anti-cancer medicinesitem30% Trade Margin Cappolicy

## **Source**

> On October 17, 2026, the National Pharmaceutical Pricing Authority (NPPA) capped the trade margin on 137 non-scheduled anti-cancer medicines, including patented ones, at 30% of the maximum retail price (MRP); revised prices take effect on November 9, 2026

*pib\_backgrounders · Telegram [ Open post](https://t.me/pib_backgrounders/763)*

## **Not established**

- Date known only to the year
- Exact year of the post update date
- Effective date of the revised MRPs
- Duration or review period of the cap

## **Extracted detail**

<dl>

<dt>Decision maker</dt>
<dd>National Pharmaceutical Pricing Authority (NPPA)</dd>

<dt>Country</dt>
<dd>India</dd>

</dl>

## **Related decisions**

Same kind only, ranked by embedding similarity to this record.

```json
{"@context":"https://schema.org","@graph":[{"@id":"https://dgw.tmarket.io/#website","@type":"WebSite","description":"Decisions, events and falsifiable forecasts from 4,500+ Telegram channels — every claim cited. Read free.","name":"DecisionGateway","url":"https://dgw.tmarket.io/","publisher":{"@id":"https://dgw.tmarket.io/#identity"}},{"@id":"https://dgw.tmarket.io/decisions/01a1df4d-5911-70a7-b913-9de5745d10de#webpage","@type":"WebPage","description":"India's NPPA capped trade margins on 137 non-scheduled anti-cancer medicines at 30% of MRP, which led companies to cut MRPs substantially and is expected to sav","name":"NPPA caps trade margin on 137 non-scheduled anti-cancer medicines at 30% of MRP — DecisionGateway","url":"https://dgw.tmarket.io/decisions/01a1df4d-5911-70a7-b913-9de5745d10de","breadcrumb":{"@id":"https://dgw.tmarket.io/decisions/01a1df4d-5911-70a7-b913-9de5745d10de#breadcrumb"},"isPartOf":{"@id":"https://dgw.tmarket.io/#website"},"potentialAction":[{"@type":"ReadAction","target":["https://dgw.tmarket.io/decisions/01a1df4d-5911-70a7-b913-9de5745d10de"]}]},{"@id":"https://dgw.tmarket.io/#identity","@type":"Organization","name":"DecisionGateway","url":"https://dgw.tmarket.io"},{"@id":"https://dgw.tmarket.io/decisions/01a1df4d-5911-70a7-b913-9de5745d10de#breadcrumb","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","name":"Home","item":"https://dgw.tmarket.io","position":1},{"@type":"ListItem","name":"Feed","item":"https://dgw.tmarket.io/feed","position":2},{"@type":"ListItem","name":"NPPA caps trade margin on 137 non-scheduled anti-cancer medicines at 30% of MRP","position":3}]}]}
```

## Sitemap

See the full [sitemap](https://dgw.tmarket.io/sitemap.md) for all pages.